UndoAge Meets Probiotics Partner Novonesis at International Exhibition
On the UndoAge website, one of the first messages customers see is: “QUALITY, VALUE, TRANSPARENCY, SAFETY.”
So where does UndoAge’s confidence in “quality” come from?
The answer lies in every step of the process, from raw material selection and factory production to strict quality control.
This time, we start from the upstream supply chain. Global raw material leaders with core patented technologies are a key foundation of UndoAge’s product strength.
Our probiotics raw material supplier, Novonesis, is a global biosolutions company with the scale and technology to influence the direction of the entire industry.
🔹 A Strong Danish Alliance: When the “Enzyme Leader” Meets the “Probiotics Leader”
In Denmark, there are two world-class companies:
Novozymes is a global leader in industrial enzymes, holding over 40% of the global industrial enzyme market and more than 4,000 active patents.
Chr. Hansen is a century-old leader in probiotics, with approximately 40,000 microbial strains and products that reach the daily lives of over 1 billion consumers.
In 2024, these two giants officially merged to form Novonesis.
This was not simply a merger. It was a major integration in the global biosolutions industry.
Novonesis holds nearly 10,000 patents and has around 2,000 R&D professionals. It not only owns one of the world’s largest microbial strain collections, but also masters core technologies across the full value chain, from microbial screening to biotransformation.
And Novonesis’ ambitions go even further.
In 2025, Novonesis entered into a deep research collaboration with Danish pharmaceutical leader Novo Nordisk.
Novo Nordisk has become a major global player in the GLP-1 market through products such as semaglutide. In 2025, the company recorded nearly USD 50 billion in revenue and over USD 16 billion in net profit. With its leadership in metabolic health, its market value once surpassed LVMH, making it Europe’s most valuable company.
This leading European pharmaceutical company will work with Novonesis to develop “probiotic + prebiotic” synbiotic dietary supplements, opening a new direction in metabolic health.
🔹 Which Products Does UndoAge Develop with Novonesis?
UndoAge’s Lactobacillus reuteri product uses the patented Pylopass™ ingredient, which has been clinically studied for its specific binding mechanism to help support the management of Helicobacter pylori-related health needs.
UndoAge Women’s Probiotics uses the patented UREX™ ingredient, one of the core raw materials in women’s health supported by substantial clinical research.
🔹【March 18, 2026 | Shanghai | International Exhibition Exchange】
At the Food Ingredients China exhibition this March, the CEO of UndoAge, together with the team, held an in-depth exchange with the China representative of Novonesis.
The purpose of the meeting was clear: to align on the latest technological developments and explore how Novonesis’ bioscience innovations can be applied to UndoAge products more quickly.
Moving forward, UndoAge will continue to deepen its collaboration with Novonesis, allowing consumers to access high-quality nutritional supplements powered by leading global bioscience, with exceptional value.
“High Quality · Affordable · Transparent · Safe” — we are always moving forward.
#UndoAge #UndoAgeTransparencyReport #Novonesis #LactobacillusReuteri #WomensProbiotics #FIC2026
